Page 4 | Certara

Blog

Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings

Discover how TFL Studio accelerates PK/PD reporting. Create audit-ready tables, figures, and listings faster with…

CertaraOctober 16, 2025

Publication

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

Danielle PillsburyOctober 15, 2025

Live Events

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

-

CertaraOctober 14, 2025

Webinar

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

US (ET): Thursday, November 6, 11:00am – 11:30am EMEA (GMT): Thursday, November 13, 10:00am –…

Danielle PillsburyOctober 10, 2025

Press Release

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

Certara to report third quarter 2025 financial results on November 6th, 2025. Company management to…

CertaraOctober 10, 2025

Webinar

RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging

CertaraOctober 9, 2025

Conference

ICAComP 2025

CertaraOctober 8, 2025

Fact Sheet

Certara IQ™ Fact Sheet

Certara IQ is the AI-enabled QSP modeling tool that will transform your research & scale…

CertaraOctober 8, 2025

Guide

MBMA vs. Meta-Analysis: Quick Comparison Guide

Discover how Model-Based Meta-Analysis (MBMA) outperforms traditional meta-analysis in drug development by predicting outcomes, informing…

CertaraOctober 8, 2025

Blog

Alzheimer’s Disease Clinical Trials and Drug Development: Building a Robust Clinical Pharmacology & Model-Informed Strategy

Rajesh Krishna proposes using an integrated clinical pharmacology & model-informed strategy for Alzheimer's disease clinical…

CertaraOctober 7, 2025

Streamlining PK/PD Reporting: A Smarter Approach to Generating Tables, Figures and Listings

Effective Visualizations Using “vachette” to Assess and Communicate Pharmacometric Model Results

PKUK 2025 Pre-Conference Workshop: Modeling & Simulation Updates – QSP and PK/PD Software

Model-Informed Drug Development (MIDD) as a tool to Enhance Asset Value and Address Key Investor Concerns

Certara to Report Third Quarter 2025 Financial Results on November 6th, 2025

RAPS Sponsored Webinar: Planning and Preparing Regulatory Submissions Using Top-down Messaging

ICAComP 2025

Certara IQ™ Fact Sheet

MBMA vs. Meta-Analysis: Quick Comparison Guide

Alzheimer’s Disease Clinical Trials and Drug Development: Building a Robust Clinical Pharmacology & Model-Informed Strategy

Newsletter sign up

Quick links

Solutions

Contact